infectious-diseases-endocrinology-2019-scientifictracks

5 / 19

Page 14
Notes:
conferenceseries.com
Volume 7 Journal of Infectious Diseases & Therapy Infectious Diseases & Endocrinology 2019
February 27-28, 2019
February 27-28, 2019 Tokyo, Japan
Infectious Diseases, Diabetes and Endocrinology
Global Experts Meeting on
Valentina A Divocha et al., J Infect Dis Ther 2019, Volume 7
DOI: 10.4172/2332-0877-C2-062
Presence of cellular components in vaccines and immunobiological drugs
Valentina A Divocha, Alya Sanctum and Alexander Kovalinsky
Lugansk State Medical University, Ukraine
Now preventive maintenance of flu by means of vaccination is conventional and is supported by experts of world. To
check presence of trypsin-like proteinase and its inhibitor in antiflu and other vaccines and in immunobiological blood
preparations of domestic and foreign manufacture. In work following commercial preparations have been used: Interferon
leukocytic human, the immunoglobulin of human placental, donor 10%, a gonococcal vaccine a herpetic vaccine (Odessa),
vaccines for preventivemaintenance of a flu, a season 2002/2003-Influvac which consists of hemagglutinins and a neuraminidase
of a virus of a flu, strains: А/Moscow/10/99 (H3N2), А/New Caledonia/20/99 (H/N), B/Hong Kong/330/2001, Fluarix which
consists of hemagglutinins of strains (H1N1) A/New Caledonia (H3N2), А/Panama and В/Shandont 17/97 and Vaxigrip which
consists of three strains of a flu virus, a vaccine for preventive maintenance of a hepatitis A - vaxim, a blood preparation
received from a heparin (the antifactor of Ha)- Fraxiparine, a preparation from a blood of calves for a hemodialysis -Solcoseryl.
Preparations were investigated before the termination of a period of validity. Work is devoted to study presence of components
of a cell-owner and its inhibitor in vaccines and blood preparations and to define presence trypsin-like proteinase and its
inhibitor in vaccines and blood preparations. It is revealed that anti influenza vaccines (Influvac, Vaxigrip, Fluarix), Herpetic
and Tularemic vaccines contained an inhibitor of trypsin-like proteinase in considerable quantity. Commercial preparations
from a human donor blood (an immunoglobulin, interferon, Fraxiparine and Solcoseryl) contained as trypsin-like proteinase
and its inhibitor. The immunoglobulin contained in 4.0 times more inhibitor, than interferon. Hence, the modern vaccines
applied to prophylaxis and treatment, are insufficiently cleared. Presence of cellular components (enzymes and inhibitors)
could lead to allergization and follow complication which is not very known.
Biography
Valentina A Divocha has completed her Graduation from I.I. Mechnikov Odessa State University, Faculty of Biology (Department of Virology). She has completed
her Post graduation studies from Odessa Institute of Virology and Epidemiology (specialty virology). She has completed her Doctoral degree with the thesis entitled,
Biological basis anti-proteinase therapy of influenza. She has many scientific publications, 3 monographs, textbook Virology (2012), 12 patents, 4 innovations. She
is currently working at Lugansk State Medical University, Ukraine. She is the Supervisor of the nine research programs in virology and biochemistry.